# Spine Wave

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spine-wave

- Industry: Medical Devices & Equipment
- Headquarters: Shelton, US
- Website: www.spinewave.com
- Total disclosed funding: $128M
- Latest round: Series D (Apr 23, 2007)
- Investors on record: 13

## About

Spine Wave, Inc. is a medical technology firm focused on developing innovative spinal solutions to enhance surgical outcomes for spine surgeons and their patients.Founded in 2001 and headquartered in Shelton, US, Spine Wave, Inc. specializes in spinal devices and has undergone nine funding deals since inception. The company raised USD 5.3 mn in VENTURE DEBT funding in July 2018, accumulating a total of USD 11.00 mn in funding. Its founder has a history of involvement in medical technology ventures.Spine Wave, Inc. specializes in developing innovative spinal solutions that cater to the needs of spine surgeons and their patients. The company’s core product offerings include a comprehensive range of expandable interbody devices, such as the Exceed® Biplanar Expandable Interbody Device and the Velocity® Expandable Interbody Device. These devices are designed for minimally invasive surgical procedures aimed at restoring spinal function, thus helping patients lead more active and pain-free lives. Additionally, Spine Wave provides various surgical systems like the Sniper® Spine System and the Stronghold® 3D Titanium Interbody Device, which are utilized in anterior and posterior spinal fusion procedures. The company serves a diverse clientele, including hospitals and surgical centers in North America and international markets, focusing on providing solutions that address real surgical challenges.Spine Wave's revenue model is primarily based on B2B transactions with healthcare providers, including hospitals and surgical facilities. The company's flagship products, such as the Leva® AF Stand-Alone ALIF System and the True Position® Pivoting Spacer System, are typically sold through direct sales teams and partnerships with surgical distributors. Transactions often involve bulk purchases, where healthcare facilities procure these advanced surgical systems for use in spinal procedures. Pricing structures are strategically set to reflect the innovative technology and clinical benefits offered by their products. Thus, the revenue framework is built around these product offerings, ensuring a steady flow of transactions as healthcare providers seek to improve surgical outcomes for their patients.Spine Wave, Inc. plans to leverage its recent VENTURE DEBT funding of USD 5.3 mn raised in July 2018 to enhance product development and market penetration. The company is currently designing new products aimed at improving surgical efficiency, with potential launches planned for 2023. Additionally, Spine Wave is focusing on expanding its presence in international markets, particularly targeting Europe and Asia by 2025.

## Funding rounds

- Series D, Apr 23, 2007, $45M — CHL Medical Partners, Morgenthaler Ventures, New Enterprise Associates, Sprout Group, Canaan Partners, Foundation Medical Partners, Thoma Bravo, California Technology Ventures, Compass Global Fund, LTD
- Series C, Feb 9, 2006, $36M — CHL Medical Partners, Morgenthaler Ventures, New Enterprise Associates, Sprout Group, Canaan Partners, Foundation Medical Partners, Thoma Bravo, California Technology Ventures
- Series B, May 17, 2004, $10M — CHL Medical Partners, Morgenthaler Ventures, New Enterprise Associates, Sprout Group, Canaan Partners, California Technology Ventures
- Series B, Nov 10, 2003, $22M — CHL Medical Partners, Morgenthaler Ventures, New Enterprise Associates, Spring Ridge Ventures, Canaan Partners, Thoma Bravo, New Venture Partners, California Technology Ventures, NeuroVentures
- Series A, Mar 20, 2002, $15M — New Enterprise Associates, Spring Ridge Ventures, Canaan Partners, New Venture Partners, California Technology Ventures, Windamere Venture Partners, NeuroVentures

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A, Series B, Series C, Series D
- Spring Ridge Ventures (https://capitalatlas.ai/funds/spring-ridge-ventures) — Series A, Series B
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A, Series B, Series C, Series D
- New Venture Partners (https://capitalatlas.ai/funds/new-venture-partners) — Series A, Series B
- California Technology Ventures (https://capitalatlas.ai/funds/california-technology-ventures) — Series A, Series B, Series C, Series D
- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series A
- NeuroVentures (https://capitalatlas.ai/funds/neuroventures) — Series A, Series B
- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series B, Series C, Series D
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series B, Series C, Series D
- Thoma Bravo (https://capitalatlas.ai/funds/thoma-bravo) — Series B, Series C, Series D
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B, Series C, Series D
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series C, Series D
- Compass Global Fund, LTD — Series D